These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5314680)

  • 21. The treatment of proteus infections in the urine with cephaloridine.
    Gardner JC; Price TM; Southwell N
    Postgrad Med J; 1967 Aug; 43():Suppl 43:74-6. PubMed ID: 6052334
    [No Abstract]   [Full Text] [Related]  

  • 22. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
    DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
    Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug-resistant H influenzae: a growing geriatric problem.
    Gleckman RA; Roth RM
    Geriatrics; 1984 Sep; 39(9):51-3, 56-8, 60. PubMed ID: 6332044
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of exacerbations of chronic bronchitis with methampicillin].
    Farina G; Zedda S
    Minerva Med; 1971 Mar; 62(22):1174-81. PubMed ID: 5551949
    [No Abstract]   [Full Text] [Related]  

  • 25. [Success in the treatment of purulent exacerbation of chronic obstructive bronchitis with antibiotics of the ampicillin group].
    Anta P; Mesic J; Kozamernik-Stojković M
    Plucne Bolesti; 1984; 36(1-2):63-5. PubMed ID: 6334862
    [No Abstract]   [Full Text] [Related]  

  • 26. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis.
    Zervos M; Martinez FJ; Amsden GW; Rothermel CD; Treadway G
    Int J Antimicrob Agents; 2007 Jan; 29(1):56-61. PubMed ID: 17189096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chephaloridine in the treatment of aged patients affected by chronic, exacerbated chronic and acute bronchopneumopathies].
    Bonini M
    G Gerontol; 1967 May; 15(5):633-8. PubMed ID: 5607150
    [No Abstract]   [Full Text] [Related]  

  • 30. [Correlation of susceptibility of organisms, dosage and clinical effects, observed in dose-response-curve in cephaloridine treatment of drug-resistant urinary tract infections].
    Seiga K
    Saishin Igaku; 1968 Nov; 23(11):2384-92. PubMed ID: 5715167
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparative study of ampicillin, tetracycline hydrochloride, and methacycline hydrochloride in acute exacerbations of chronic bronchitis.
    Malone DN; Gold JC; Grant IW
    Lancet; 1968 Sep; 2(7568):594-6. PubMed ID: 4175157
    [No Abstract]   [Full Text] [Related]  

  • 32. The management of purulent exacerbations of chronic bronchitis. A comparison of minocycline and tetracycline hydrochloride.
    Pines A; Raafat H; Sreedharan KS
    Practitioner; 1974 Nov; 213(1277):727-9. PubMed ID: 4617213
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the treatment of chronic bronchitis, a therapeutic study].
    Renovanz HD; Liebrich KG
    Arzneimittelforschung; 1967 Jan; 17(1):37-46. PubMed ID: 5632525
    [No Abstract]   [Full Text] [Related]  

  • 34. Decontamination of contaminated axenic mice.
    Titus JL; Wellman WE; Henderson JD
    Mayo Clin Proc; 1968 Jul; 43(7):540-2. PubMed ID: 5710587
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of nephrotoxicity during cephaloridine therapy for urinary-tract infection.
    Winchester JF; Kennedy AC
    Lancet; 1972 Sep; 2(7776):514-6. PubMed ID: 4115572
    [No Abstract]   [Full Text] [Related]  

  • 36. CEPHALORIDINE IN CHRONIC BRONCHITIS.
    JONES DM; DAVIS P
    Br Med J; 1965 Feb; 1(5432):448-9. PubMed ID: 14237936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnostic and therapeutic strategies in exacerbations of chronic bronchitis in city practice].
    Taytard A; Vernejoux JM; Villanueva P; Tunon De Lara JM
    Rev Mal Respir; 1995; 12(4):371-6. PubMed ID: 7481050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of the chronic bronchitis syndrome using a new preparation M 811].
    Eiter E
    Wien Med Wochenschr; 1968 Apr; 118(14):303-7. PubMed ID: 5672075
    [No Abstract]   [Full Text] [Related]  

  • 39. Cephaloridine compared with penicillin and streptomycin in chronic purulent bronchitis. Controlled trials of increasing dosage of cephaloridine.
    Pines A; Raafat H; Plucinski K; Greenfield JS; Linsell WD
    Br J Dis Chest; 1967 Apr; 61(2):101-10. PubMed ID: 6033812
    [No Abstract]   [Full Text] [Related]  

  • 40. The efficacy of moxifloxacin in acute exacerbations of chronic bronchitis: a Spanish physician and patient experience.
    Miravitlles M; Ros F; Cobos A; Kubin R; Tillotson G
    Int J Clin Pract; 2001 Sep; 55(7):437-41. PubMed ID: 11594251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.